SHP-2 inhibits tyrosine phosphorylation of Cas-L and regulates cell migration

Biochemical and Biophysical Research Communications

Volumn 382, Issue 1, 2009, Pages 210-214

  Yo, Koji ^a   Iwata, Satoshi ^a   Hashizume, Yutaka ^a   Kondo, Shunsuke ^a   Nomura, Sayaka ^a   Hosono, Osamu ^a   Kawasaki, Hiroshi ^a   Tanaka, Hirotoshi ^a   Dang, Nam H ^b   Morimoto, Chikao ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b NEVADA CANCER INSTITUTE   (United States)

Author keywords

Cas L; Cell migration; Focal adhesion; SHP 2; Tyrosine phosphorylation

Indexed keywords

CRK ASSOCIATED SUBSTRATE PROTEIN; FIBRONECTIN; PROTEIN TYROSINE PHOSPHATASE SHP; PROTEIN TYROSINE PHOSPHATASE SHP 2;

ARTICLE; CELL MIGRATION; COMPLEX FORMATION; CONTROLLED STUDY; FOCAL ADHESION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE, TUMOR; CELL MOVEMENT; FOCAL ADHESIONS; HUMANS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; SEQUENCE DELETION; TYROSINE;

EID: 63149148150     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.010     Document Type: Article

References (32)

1. Minegishi M., Tachibana K., Sato T., Iwata S., Nojima Y., and Morimoto C. Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes. J. Exp. Med. 184 (1996) 1365-1375
2. Natarajan M., Stewart J.E., Golemis E.A., Pugacheva E.N., Alexandropoulos K., Cox B.D., Wang W., Grammer J.R., and Gladson C.L. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 25 (2006) 1721-1732
3. Kim M., Gans J.D., Nogueira C., Wang A., Paik J.H., Feng B., Brennan C., Hahn W.C., Cordon-Cardo C., Wagner S.N., Flotte T.J., Duncan L.M., Granter S.R., and Chin L. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125 (2006) 1269-1281
4. Ohashi Y., Iwata S., Kamiguchi K., and Morimoto C. Tyrosine phosphorylation of Crk-associated substrate lymphocyte-type is a critical element in TCR- and beta 1 integrin-induced T lymphocyte migration. J. Immunol. 163 (1999) 3727-3734
5. van Seventer G.A., Salmen H.J., Law S.F., O'Neill G.M., Mullen M.M., Franz A.M., Kanner S.B., Golemis E.A., and van Seventer J.M. Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway. Eur. J. Immunol. 31 (2001) 1417-1427
6. Iwata S., Souta-Kuribara A., Yamakawa A., Sasaki T., Shimizu T., Hosono O., Kawasaki H., Tanaka H., Dang N.H., Watanabe T., Arima N., and Morimoto C. HTLV-I Tax induces and associates with Crk-associated substrate lymphocyte type (Cas-L). Oncogene 24 (2005) 1262-1271
7. Ji H., Ramsey M.R., Hayes D.N., Fan C., McNamara K., Kozlowski P., Torrice C., Wu M.C., Shimamura T., Perera S.A., Liang M.C., Cai D., Naumov G.N., Bao L., Contreras C.M., Li D., Chen L., Krishnamurthy J., Koivunen J., Chirieac L.R., Padera R.F., Bronson R.T., Lindeman N.I., Christiani D.C., Lin X., Shapiro G.I., Janne P.A., Johnson B.E., Meyerson M., Kwiatkowski D.J., Castrillon D.H., Bardeesy N., Sharpless N.E., and Wong K.K. LKB1 modulates lung cancer differentiation and metastasis. Nature 448 (2007) 807-810
8. Law S.F., Zhang Y.Z., Klein-Szanto A.J., and Golemis E.A. Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments. Mol. Cell Biol. 18 (1998) 3540-3551
9. Dadke D., Jarnik M., Pugacheva E.N., Singh M.K., and Golemis E.A. Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle. Mol. Biol. Cell 17 (2006) 1204-1217
10. Pugacheva E.N., and Golemis E.A. HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks. Cell Cycle 5 (2006) 384-391
11. Pugacheva E.N., and Golemis E.A. The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. Nat. Cell Biol. 7 (2005) 937-946
12. O'Neill G.M., and Golemis E.A. Proteolysis of the docking protein HEF1 and implications for focal adhesion dynamics. Mol. Cell Biol. 21 (2001) 5094-5108
13. Law S.F., O'Neill G.M., Fashena S.J., Einarson M.B., and Golemis E.A. The docking protein HEF1 is an apoptotic mediator at focal adhesion sites. Mol. Cell Biol. 20 (2000) 5184-5195
14. Ohashi Y., Tachibana K., Kamiguchi K., Fujita H., and Morimoto C. T cell receptor-mediated tyrosine phosphorylation of Cas-L, a 105-kDa Crk-associated substrate-related protein, and its association of Crk and C3G. J. Biol. Chem. 273 (1998) 6446-6451
15. Ren Y., Meng S., Mei L., Zhao Z.J., Jove R., and Wu J. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor. J. Biol. Chem. 279 (2004) 8497-8505
16. Manes S., Mira E., Gomez-Mouton C., Zhao Z.J., Lacalle R.A., and Martinez A.C. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol. Cell Biol. 19 (1999) 3125-3135
17. Guo H.B., Randolph M., and Pierce M. Inhibition of a specific N-glycosylation activity results in attenuation of breast carcinoma cell invasiveness-related phenotypes: inhibition of epidermal growth factor-induced dephosphorylation of focal adhesion kinase. J. Biol. Chem. 282 (2007) 22150-22162
18. Wang C.Z., Su H.W., Hsu Y.C., Shen M.R., and Tang M.J. A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration. Mol. Biol. Cell 17 (2006) 2839-2852
19. Mathew S., George S.P., Wang Y., Siddiqui M.R., Srinivasan K., Tan L., and Khurana S. Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration. J. Biol. Chem. 283 (2008) 22709-22722
20. Inamoto S., Iwata S., Inamoto T., Nomura S., Sasaki T., Urasaki Y., Hosono O., Kawasaki H., Tanaka H., Dang N.H., and Morimoto C. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7. Oncogene 26 (2007) 893-904
21. Milarski K.L., and Saltiel A.R. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 269 (1994) 21239-21243
22. Agazie Y.M., and Hayman M.J. Development of an efficient "Substrate-trapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates. J. Biol. Chem. 278 (2003) 13952-13958
23. Kolli S., Zito C.I., Mossink M.H., Wiemer E.A., and Bennett A.M. The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J. Biol. Chem. 279 (2004) 29374-29385
24. Law S.F., Estojak J., Wang B., Mysliwiec T., Kruh G., and Golemis E.A. Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae. Mol. Cell Biol. 16 (1996) 3327-3337
25. Yu D.H., Qu C.K., Henegariu O., Lu X., and Feng G.S. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J. Biol. Chem. 273 (1998) 21125-21131
26. Oh E.S., Gu H., Saxton T.M., Timms J.F., Hausdorff S., Frevert E.U., Kahn B.B., Pawson T., Neel B.G., and Thomas S.M. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2. Mol. Cell Biol. 19 (1999) 3205-3215
27. Garton A.J., Flint A.J., and Tonks N.K. Identification of p130(cas) as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST. Mol. Cell Biol. 16 (1996) 6408-6418
28. Ceacareanu A.C., Ceacareanu B., Zhuang D., Chang Y., Ray R.M., Desai L., Chapman K.E., Waters C.M., and Hassid A. Nitric oxide attenuates IGF-I-induced aortic smooth muscle cell motility by decreasing Rac1 activity: essential role of PTP-PEST and p130cas. Am. J. Physiol. Cell Physiol. 290 (2006) C1263-C1270
29. Sattler M., Mohi M.G., Pride Y.B., Quinnan L.R., Malouf N.A., Podar K., Gesbert F., Iwasaki H., Li S., Van Etten R.A., Gu H., Griffin J.D., and Neel B.G. Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 1 (2002) 479-492
30. Scherr M., Chaturvedi A., Battmer K., Dallmann I., Schultheis B., Ganser A., and Eder M. Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML). Blood 107 (2006) 3279-3287
31. Chen J., Yu W.M., Daino H., Broxmeyer H.E., Druker B.J., and Qu C.K. SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl. Blood 109 (2007) 778-785
32. Bentires-Alj M., Gil S.G., Chan R., Wang Z.C., Wang Y., Imanaka N., Harris L.N., Richardson A., Neel B.G., and Gu H. A role for the scaffolding adapter GAB2 in breast cancer. Nat. Med. 12 (2006) 114-121